Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01023411
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
NA4![]() | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)- PYRIDIN-3-YL]-BENZOIC ACID | A,C | 1RHM | 0.74 | ![]() |
824![]() | 9-HYDROXY-4-PHENYLPYRROLO[3,4-C]CARBAZOLE- 1,3(2H,6H)-DIONE | A | 1X8B | 0.7 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A,B | 2DAA | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A,B,C,D | 2RJH | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A | 1D7S | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A,B | 1EPV | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A | 1I2L | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A,B | 1NIU | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A,B | 1VFS | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A,B | 1VFT | 0.71 | ![]() |
DCS![]() | D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A | 1MDZ | 0.71 | ![]() |
PXL![]() | 3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYLISONICOTINALDEHYDE | A,B | 3FHX | 0.7 | ![]() |
PXL![]() | 3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYLISONICOTINALDEHYDE | A,B | 2DDW | 0.7 | ![]() |
PXL![]() | 3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYLISONICOTINALDEHYDE | A,B | 2Z9W | 0.7 | ![]() |
PXL![]() | 3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYLISONICOTINALDEHYDE | A,B | 2Z9X | 0.7 | ![]() |
PXL![]() | 3-HYDROXY-5-(HYDROXYMETHYL)-2-METHYLISONICOTINALDEHYDE | A,B | 1TD2 | 0.7 | ![]() |
SRO![]() | SEROTONIN | A,B | 3BRN | 0.71 | ![]() |
SRO![]() | SEROTONIN | A | 2QEH | 0.71 | ![]() |
IID![]() | N-(1-ISOPROPYLPIPERIDIN-4-YL)-1- (3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | A,B | 2BQ7 | 0.71 | ![]() |
VX1![]() | 4-[3-(4-chlorophenyl)-2,1-benzisoxazol- 5-yl]pyrimidin-2-amine | A | 3BGP | 0.7 | ![]() |
BI5![]() | 4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE | A | 1ZYJ | 0.75 | ![]() |
LI7![]() | (3E)-3-[(4-HYDROXYPHENYL)IMINO]- 1H-INDOL-2(3H)-ONE | A | 1YXX | 0.7 | ![]() |
NNO![]() | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCK | 0.74 | ![]() |
NNO![]() | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCM | 0.74 | ![]() |
3ID![]() | 3H-INDOLE-5,6-DIOL | A | 1F9B | 0.71 | ![]() |
3ID![]() | 3H-INDOLE-5,6-DIOL | A | 1OYO | 0.71 | ![]() |
ICO![]() | 1H-INDOLE-3-CARBOXYLIC ACID | L | 2PIP | 0.74 | ![]() |
4HG![]() | N-[(4-HYDROXY-8-IODOISOQUINOLIN- 3-YL)CARBONYL]GLYCINE | A | 2G19 | 0.74 | ![]() |
4HG![]() | N-[(4-HYDROXY-8-IODOISOQUINOLIN- 3-YL)CARBONYL]GLYCINE | A | 2G1M | 0.74 | ![]() |
LG2![]() | 6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8- TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE- 3-CARBOXYLIC ACID | A,B,C,D | 1H9U | 0.72 | ![]() |
SYB![]() | 4-[4-(DIMETHYLAMINO)-N-METHYL-L- PHENYLALANINE]-5-[(2S,5R)-5-[[[(3S)- 1-AZABICYCLO-[2.2.2]OCT-3-YL]THIO]METHYL]- 4-OXO-2-PIPERIDINECARBOXYLIC ACID]VIRGINIAMYCIN | A,B | 2Z2P | 0.7 | ![]() |
SYB![]() | 4-[4-(DIMETHYLAMINO)-N-METHYL-L- PHENYLALANINE]-5-[(2S,5R)-5-[[[(3S)- 1-AZABICYCLO-[2.2.2]OCT-3-YL]THIO]METHYL]- 4-OXO-2-PIPERIDINECARBOXYLIC ACID]VIRGINIAMYCIN | 0,1,3,9,A,B, C,H,J,K,L,M, N,O,Q,R,S,T, U,Y,Z | 1YJW | 0.7 | ![]() |
SYB![]() | 4-[4-(DIMETHYLAMINO)-N-METHYL-L- PHENYLALANINE]-5-[(2S,5R)-5-[[[(3S)- 1-AZABICYCLO-[2.2.2]OCT-3-YL]THIO]METHYL]- 4-OXO-2-PIPERIDINECARBOXYLIC ACID]VIRGINIAMYCIN | 0 | 1SM1 | 0.7 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.74 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.74 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.74 | ![]() |
839![]() | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL- 2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL- 6(1H)-YL)PROPANOIC ACID | A | 2IN6 | 0.71 | ![]() |
NPV![]() | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A,B | 2QYN | 0.71 | ![]() |
NPV![]() | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A,B | 2QYK | 0.71 | ![]() |
NPV![]() | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A | 2QYL | 0.71 | ![]() |
OAI![]() | 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID | A | 1C83 | 0.73 | ![]() |
TRX![]() | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L,M | 1K83 | 0.75 | ![]() |
TRX![]() | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L, M,T | 2VUM | 0.75 | ![]() |
TRX![]() | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L,M | 3CQZ | 0.75 | ![]() |
PLT![]() | [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-L-TRYPTOPHANE | B | 2TYS | 0.7 | ![]() |
WAY![]() | N-HYDROXY-2-[(4-METHOXY-BENZENESULFONYL)- PYRIDIN-3-YLMETHYL-AMINO]-3-METHYL- BENZAMIDE | A | 1FLS | 0.71 | ![]() |
WAY![]() | N-HYDROXY-2-[(4-METHOXY-BENZENESULFONYL)- PYRIDIN-3-YLMETHYL-AMINO]-3-METHYL- BENZAMIDE | A | 1FM1 | 0.71 | ![]() |
ARH![]() | 3-(HYDROXYMETHYL)-1-METHYL-5-(2- METHYLAZIRIDIN-1-YL)-2-PHENYL-1H- INDOLE-4,7-DIONE | A,B,C,D | 1H69 | 0.71 | ![]() |
I05![]() | (3R,4R)-N-{4-[4-(2-FLUORO-6-HYDROXY- 3-METHOXY-BENZOYL)-BENZYLOXY]-AZEPAN- 3-YL}-ISONICOTINAMIDE | A | 1VEB | 0.7 | ![]() |
R96![]() | N-[4-({4-[5-(3,3-DIMETHYLPIPERIDIN- 1-YL)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH7 | 0.73 | ![]() |
I08![]() | (3R,4S)-N-(4-{TRANS-2-[4-(2-FLUORO- 6-HYDROXY-3-METHOXY-BENZOYL)-PHENYL]- VINYL}-AZEPAN-3-YL)-ISONICOTINAMIDE | A | 1SVH | 0.71 | ![]() |
FLL![]() | OCTAHEDRAL RU-PYRIDOCARBAZOLE | A | 3FXZ | 0.7 | ![]() |
AG7![]() | 4-{2-(4-FLUORO-BENZYL)-6-METHYL- 5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)- AMINO]-4-OXO-HEPTANOYLAMINO}-5- (2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER | A | 1CQQ | 0.71 | ![]() |
IOK![]() | N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]- 2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE | A,B | 2IOK | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1JHQ | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1L5L | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 2F7F | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1L5K | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1JHY | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A,B | 1FSL | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1L5M | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1LH6 | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1JHO | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 3CI8 | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A,B,C,D | 1ICU | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A,B,C,D,E,F, G,H | 3HRD | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1JHA | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1JHV | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1L4N | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 2LH6 | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1D0V | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A,B,C,D | 1ICV | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A,B | 1ICR | 0.7 | ![]() |
NIO![]() | NICOTINIC ACID | A | 1JHR | 0.7 | ![]() |
D1G![]() | N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN- 2-YL)METHANAMINE | A,B,C,D | 2FDU | 0.71 | ![]() |
826![]() | 1,3,4,9-TETRAHYDRO-2-(HYDROXYBENZOYL)- 9-[(4-HYDROXYPHENYL)METHYL]-6-METHOXY- 2H-PYRIDO[3,4-B]INDOLE | A,B | 1I30 | 0.74 | ![]() |
BLP![]() | (5-HYDROXY-6-METHYL-4-((2-(2-(2- NITROBENZAMIDO)ACETYL)HYDRAZINYL)METHYL)PYRIDIN- 3-YL)METHYL DIHYDROGEN PHOSPHATE | A,B | 2GQN | 0.77 | ![]() |
1FR![]() | 3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4- c]pyridin-3-yl)phenyl]propan-1- ol | A | 3DB8 | 0.73 | ![]() |
2GJ![]() | 5-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]- N-ETHYL-4-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]ISOXAZOLE- 3-CARBOXAMIDE | A | 2VCI | 0.72 | ![]() |
HRP![]() | 5-HYDROXY-L-TRYPTOPHAN | B | 1YIA | 0.74 | ![]() |
897![]() | N-[3-(TERT-BUTYLAMINO)-3-OXOPROPYL]- N-ISOPROPYL-3-METHYL-5-{[(2S)-2- (PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | B,H | 2UUK | 0.7 | ![]() |
R68![]() | N-{4-[(4-{3-[(2R)-3,3-DIMETHYLPIPERIDIN- 2-YL]-2-FLUORO-6-HYDROXYBENZOYL}BENZOYL)AMINO]AZEPAN- 3-YL}ISONICOTINAMIDE | A | 1XHA | 0.73 | ![]() |
R68![]() | N-{4-[(4-{3-[(2R)-3,3-DIMETHYLPIPERIDIN- 2-YL]-2-FLUORO-6-HYDROXYBENZOYL}BENZOYL)AMINO]AZEPAN- 3-YL}ISONICOTINAMIDE | A,B | 1XH5 | 0.73 | ![]() |
PYU![]() | 2-(1H-pyrrol-1-ylcarbonyl)benzene- 1,3,5-triol | A,B | 3EKO | 0.73 | ![]() |
AKP![]() | N-(PYRAZIN-2-YLCARBONYL)LEUCYLISOLEUCYL- N~1~-{1-[2-({1-CARBOXY-2-[4-(PHOSPHONOOXY)PHENYL]ETHYL}AMINO)- 1,1-DIHYDROXY-2-OXOETHYL]BUT-3- ENYL}-3-CYCLOHEXYLALANINAMIDE | A,B | 1RGQ | 0.7 | ![]() |
NTM![]() | QUINOLINIC ACID | A | 3C2O | 0.74 | ![]() |
NTM![]() | QUINOLINIC ACID | A,B | 1QAP | 0.74 | ![]() |
NTM![]() | QUINOLINIC ACID | A,B,C,D,E,F | 1QPQ | 0.74 | ![]() |
NTM![]() | QUINOLINIC ACID | A,B,C | 2B7N | 0.74 | ![]() |
3HI![]() | (3R,5R)-7-[2-(4-fluorophenyl)-4- [(2-hydroxyphenyl)carbamoyl]-5- (1-methylethyl)-3-phenyl-1H-pyrrol- 1-yl]-3,5-dihydroxyheptanoic acid | B,C,D | 3CCT | 0.7 | ![]() |
3HM![]() | 5-hydroxy-6-methylpyridine-3-carboxylic acid | A,B | 3GMC | 0.75 | ![]() |
PMH![]() | (5-HYDROXY-4-{[(3-HYDROXYISOXAZOL- 4-YL)AMINO]METHYL}-6-METHYLPYRIDIN- 3-YL)METHYL DIHYDROGEN PHOSPHATE | A,B | 1XQL | 0.73 | ![]() |
PMH![]() | (5-HYDROXY-4-{[(3-HYDROXYISOXAZOL- 4-YL)AMINO]METHYL}-6-METHYLPYRIDIN- 3-YL)METHYL DIHYDROGEN PHOSPHATE | A,B | 1XQK | 0.73 | ![]() |
R55![]() | N-[4-({4-[5-(4,4-DIMETHYLPIPERIDIN- 1-YL)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH8 | 0.73 | ![]() |
3IH![]() | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A | 2HOB | 0.7 | ![]() |
3IH![]() | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2AMQ | 0.7 | ![]() |
3IH![]() | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B,C,D | 3D23 | 0.7 | ![]() |
3IH![]() | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2Q6F | 0.7 | ![]() |
PXG![]() | 3-[O-PHOSPHONOPYRIDOXYL]--AMINO- BENZOIC ACID | A | 1B9I | 0.76 | ![]() |
D3G![]() | (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE | A,B,C,D | 2FDW | 0.73 | ![]() |
R94![]() | N-(4-{[4-(2-HYDROXY-5-PIPERIDIN- 1-YLBENZOYL)BENZOYL]AMINO}AZEPAN- 3-YL)ISONICOTINAMIDE | A | 1XH6 | 0.75 | ![]() |
INO![]() | 2-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCL | 0.72 | ![]() |
INO![]() | 2-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCJ | 0.72 | ![]() |
D2G![]() | N-METHYL(5-(PYRIDIN-3-YL)FURAN- 2-YL)METHANAMINE | A,B,C,D | 2FDV | 0.72 | ![]() |
LCS![]() | L-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE | A | 1D7U | 0.71 | ![]() |
1IQ![]() | 2-(4-ISOPROPYL-4-METHYL-5-OXO-4,5- DIHYDRO-1H-IMIDAZOL-2-YL)QUINOLINE- 3-CARBOXYLIC ACID | A | 1Z8N | 0.72 | ![]() |
39Z![]() | 5-HYDROXY-3-[(1R)-1-(1H-PYRROL- 2-YL)ETHYL]-2H-INDOL-2-ONE | A | 2PE0 | 0.74 | ![]() |
0AF![]() | 7-hydroxy-L-tryptophan | L | 1MAE | 0.7 | ![]() |
0AF![]() | 7-hydroxy-L-tryptophan | L | 1MAF | 0.7 | ![]() |
5MR![]() | NALPHA-{(2S)-3-[(S)-HYDROXY(PHENYL)PHOSPHORYL]- 2-[(3-PHENYLISOXAZOL-5-YL)METHYL]PROPANOYL}- L-TRYPTOPHANAMIDE | A,B | 2OVZ | 0.75 | ![]() |
AGE![]() | (2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)- 1H-pyrrol-2-yl]prop-2-enamide | A,B,C | 3F07 | 0.73 | ![]() |
I04![]() | N-{(3R,4R)-4-[4-(2-FLUORO-6-HYDROXY- 3-METHOXY-BENZOYL)-BENZOYLAMINO]- AZEPAN-3-YL}ISONICOTINAMIDE | A | 1SVG | 0.7 | ![]() |
BMS![]() | A,B | 1DKF | 0.71 | ![]() | |
P3F![]() | PHOSPHORIC ACID MONO-(5-HYDROXY- 6-METHYL-4-{[2-(2-TRIFLUOROMETHYL- BENZOYLAMINO)-ACETYL]-HYDRAZONOMETHYL}- PYRIDIN-3-YLMETHYL)ESTER | A,B | 2FQ6 | 0.73 | ![]() |
547![]() | 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3- B]PYRIDIN-4-AMINE | A | 2OF2 | 0.7 | ![]() |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RU9 | 0.76 | ![]() |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RUM | 0.76 | ![]() |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RUL | 0.76 | ![]() |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RUA | 0.76 | ![]() |
NFL![]() | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.72 | ![]() |
VRS![]() | VIRGINIAMYCIN S1 | 0,1,2,3,9,A, B,C,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 1YIT | 0.76 | ![]() |
859![]() | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.78 | ![]() |
R69![]() | N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH4 | 0.76 | ![]() |
R69![]() | N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH9 | 0.76 | ![]() |
ASE![]() | N-ACETYL SEROTONIN | A | 1NAS | 0.73 | ![]() |
HQA![]() | 3-(8-hydroxyquinolin-3-yl)-L-alanine | A,B | 3FCA | 0.72 | ![]() |
896![]() | N-ETHYL-N-ISOPROPYL-3-METHYL-5- {[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | B,H | 2UUJ | 0.71 | ![]() |